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We designed a new complex drug with antiallergic effect containing, in addition to the main 
component loratadine, a phytocomplex for an extra therapeutic effect. A collection of plants 
with sedative activity is chosen and the optimal agent for extraction of bioactive compounds 
(40% ethanol) and optimal degree of plant fragmentation are determined. Chemical composi-
tion of the sedative tea is evaluated by reverse phase HPLC. The marker components of the 
species are detected: xanthohumol and isoxanthohumol — Humulus lupulus cone components, 
Mentha piperita rosmarinic acid, and scutellareine, Menyanthes trifolia element — quercetin-
3-rutinoside, and caffeic acid. Standardization of the species by the absolute graduation 
method in conversion to quercetin-3-rutinoside is suggested.
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Numerous rectal suppositories with various therapeu-
tic effects, local and total systems, are available. High-
molecular compounds, such as insulin and heparin, 
can also be administered per rectum. Suppositories are 
used for painless premedication, induction anesthesia 
and basal narcosis; rectal administration of drugs is 
used in cardiological practice [3,7]. In some countries 
(France, Italy, and Ukraine) drugs in rectal supposito-
ria dosage form are used for the treatment of allergic 
conditions.
As a rule, the composition of antihistaminic drugs 
is not supplemented with substances relieving the clin-
ical symptoms of allergy [9]. Phytocomplexes of some 
medicinal plants with soft target pharmacological ac-
tivity seem to be useful for the purpose [5].
The rectal dosage form with antihistaminic activ-
ity (loratadin) is supplemented with an active com-
ponent (phytocomplex), relieving the negative symp-
toms of allergic disease [8]. Together with loratadine, 
a thick extract from medicinal plant species of the 
following composition is added into the suppositoria 
mass: Mentha piperita L. leaves, Menyanthes trifolia 
L. (buckbean) leaves, Valeriana officinalis L. rhizome 
with roots, and Humulus lupulus L. cones [1,5,9]. The 
predicted pharmacological response is based on the 
proven characteristics of the active components of the 
phytocomplex. These plants contain polyphenol com-
plexes with sedative, anti-inflammatory, antioxidant, 
and antihistaminic effects [2].
The aim of this part of the study is the develop-
ment of analytical instruments for complex support of 
the process of innovation dosage form creation. The 
innovation in the pharmaceutical technology of this 
dosage form is the use of mechanochemistry approach 
[4]. Realization of our target includes the following 
problems: to find the optimal extractant for attain-
ing the maximum output of bioactive substances from 
sedative complex; to determine the acceptable degree 
of sedative plant fragmentation, at which the extrac-
tion of the active components would be the maximum; 
to detect the chemical composition and suggest a me-
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thod for standardization of the sedative species by the 
marker components.
MATERIALS AND METHODS
Valerian rhizome with root (FS.2.5.0009.15), pe pper-
mint leaves (FS.2.5.0029.15), hops cones (FS.2.5. 
0046.15), buckbean leaves (State Pharmacopoeia XI), 
ethanol 40.70, 95% (State Pharmacopoeia X, GOST), 
and pure water (FS 42-0324-09) were used in the 
study. The test object was separated by reverse phase 
HPLC.
Chromatographic studies were carried out on a 
device (Agilent Technologies 1200 Infinity) with an 
automated sample selector Agilent 1200, vacuum mi-
crodegasifier, gradient pump, and a thermostat of the 
same series, and diode matrix spectrophotometric detec-
tor Agilent 1200 (λ=190-195 nm) with a 2-nm scanning 
step. Spectral data and chromatograms were recorded 
and processed using Agilent Chem Station software.
Chromatographic column Supelco Ascentis ex-
press C18 2.7 µ×100 mm×4.6 mm was used; mobile 
phase velocity 0.5 ml/min, temperature 35oC, sample 
volume 1 µl. Mobile phase: 1.0% water solution of 
formic acid (A) — 95% ethanol (B) in the gradient 
elution mode. The mobile phase composition varied 
from 90 to 10% phase A over 40 min [6]. Flavonoids 
were detected at λ=350 nm, hydroxycinnamic acids 
and flavones at λ=325 nm, and chalcones at λ=370 nm.
RESULTS
In order to select the optimal concentration of the 
extractant, a series of extractions from the studied 
sedative tea was carried out with the solvent (ethanol) 
in concentrations of 40, 60, 70, and 90%. The resul-
tant extracts were chromatographied. The output of 
bioactive compounds extracted from the species was 
evaluated by comparing the areas of peaks in chro-
matograms. The bioactive compounds output was the 
highest after extraction by 40% ethanol.
Stage two of the study was selection of the op-
timal degree of fragmentation. The sedative tea was 
fragmented on a ball vibratory mill during 15, 30, or 
45 min. Fragmented objects were then subjected to 
extraction in 40% ethanol and the resultant extracts 
were fractionated by chromatography. The output of 
bioactive compounds extracted from fragmented ob-
jects was evaluated by the sum of peaks of bioac-
tive compounds. The highest output of the complex 
of substances was attained after the phytocomplex 
fragmentation for 45 min.
The next step of our study was detection of the 
marker components of the species, by which it could 
be standardized.
The studied composition includes peppermint 
leaves, buckbean leaves, valerian rhizome with root, 
and hops cones. The chromatogram shows the marker 
components characteristic of these plants. Figure 1 
presents the chromatogram of 40% ethanol extraction 
of the species, recorded at λ=350 nm. The main ele-
ments of the species are xanthohumol and isoxantho-
humol — peppermint constituents, rosmarinic acid and 
scutellareine — peppermint components, quercetin-
3-rutinoside — buckbean constituent, and caffeic acid 
present in all these plants (Fig. 2).
These data suggest standardization of the compo-
sition by the above components. However, not all the 
standard specimens of these components are commer-
cially available, and hence, we suggest standardization 
by one element of the composition — by quercetin-
3-rutinoside.
The absolute graduation method was used for 
standardization of the composition. Calibration curve 
was plotted by the standard sample of quercetin-3-ru-
tinoside in concentrations of 0.064-0.800 mg/ml. The 
curve demonstrated a direct relationship between the 
standard sample concentrations and the analytical sig-
nal (peak area).
The area of the peak corresponding to rutin was 
measured for the analyzed object, and the quantity 
was calculated from the calibration curve according 
to the formula:
CCT×W×100                       x= ,m×(100-B)
where CCT was the quantity of flavonoids found in the 
calibration curve (%), m — weight of the sample (g), 
W — dilution of the sample, and D — weight loss 
after the sample drying (g).
The results of quantitative evaluation of flavo-
noids in conversion to quercetin-3-rutinoside were pre-
sented in Table 1. The content of rutin in the sedative 
tea specimen was 1.830±0.052%. The error of a single 
measurement was no more than 5%, which was within 
the range allowed by the State Pharmacopoeia.
TABLE 1. Results of Rutin Measurements in Sedative Tea
Parameter Value
f 5
x 1.83
s 0.02132
P, % 95
t(P, f) 2.57
Δ 0.05225
ε, % 2.86
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The studies have determined the optimal extract-
ant for extraction of the complex of bioactive com-
pounds from the sedative tea: 40% ethanol. The op-
timal degree of the phytocomplex fragmentation is 
determined. The best output of the complex of bioac-
tive compounds is attained after fragmentation of the 
species during 45 min. The chemical composition of 
the sedative species is detected. The marker compo-
nents of the species are determined: xanthohumol and 
isoxanthohumol — hops cone components, rosma-
rinic acid and scutellareint — peppermint constitu-
ents, quercetin-3-rutinoside — buckbean element, and 
caffeic acid. A method for quantitative evaluation of 
the species is suggested: absolute graduation method 
in the course of chromatography with conversion to 
quercetin-3-rutinoside. The content of this component 
in the composition is 1.830±0.052%, with the single 
measurement error of 2.86%.
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Fig. 1. Chromatogram of sedative tea polyphenol separation (diode matrix detection, λ=350 nm).
Fig. 2. Diode matrix detection of sedative tea components. tR: time of the component retention in chromatogram.
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